Tri Chemical Laboratories Inc.JP:4369
Market cap
¥84.4B
P/E ratio
17.6x
| 2015/01 | 2016/01 | 2017/01 | 2018/01 | 2019/01 | 2020/01 | 2021/01 | 2022/01 | 2023/01 | 2024/01 | 2025/01 | |
| Depreciation & amortization | 235 | 266 | 338 | 373 | 484 | 642 | 814 | 1,019 | 1,210 | 1,305 | 1,372 |
| Cash from operations | 370 | 505 | 1,484 | 1,135 | 1,411 | 1,810 | 2,090 | 3,639 | 6,392 | 2,972 | 3,675 |
| Capital expenditures | -337 | -609 | -856 | -929 | -1,199 | -1,405 | -2,925 | -881 | -1,530 | -1,740 | -3,069 |
| Cash from investing | -340 | -610 | -1,009 | -1,536 | -1,245 | -1,564 | -2,964 | -933 | -1,558 | -1,782 | -3,116 |
| Payments for dividends | -14 | -53 | -78 | -125 | -164 | -350 | -454 | -531 | -650 | -974 | -974 |
| Repurchases of common stock | - | - | - | -0 | -0 | -0 | -1 | - | -0 | - | -0 |
| Proceeds from issuance of term debt, net | 500 | 700 | 700 | 700 | 1,120 | 930 | 2,070 | 500 | - | - | 200 |
| Repayments of term debt | -191 | -290 | -437 | -534 | -682 | -731 | -583 | -616 | -961 | -785 | -738 |
| Cash from financing | 358 | 146 | 190 | 39 | 270 | -226 | 948 | 3,594 | -1,704 | -1,859 | -1,620 |
| Free cash flow | |||||||||||
| FCF margin (%) |